InsidersTradesSigma
Track the HEM파마 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, HEM파마 has logged 0 reports. Market capitalisation: €286.3bn. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
No declarations found
0 of 0 declarations
HEM파마 是一家在健康和制药领域运营的公司，在XKRX市场上市。它专注于药品的开发和销售。